Meal Timing, Genetics and Weight Loss
ConditionObesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversidad de Murcia
About this trial
Meal times differ from culture to culture. These differences may influence energy regulation and, consequently, body weight. Current studies support the notion that not only "what" but also "when" the investigators eat may have a significant role in obesity treatment. Recently, it has been shown that eating the main meal of the day, lunch in Spain, late in the day is predictive of difficulty in weight loss and decreased insulin sensitivity. This project aims to study in a Mediterranean population the potential influence of genetics and food timing on obesity, metabolic syndrome and weight loss.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Body Mass Index: >25 kg/m2
Age: >18 years of age
Caucasian
Disqualifiers
Receiving treatment with thermogenic, lipogenic, or contraceptive drugs
Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis
bulimia diagnosis, prone to binge eating
undergoing treatment with anxiolytic or antidepressant drugs
Trial population
All participants are voluntarily attending five weight loss clinics in Spain for dietetic and behavioral treatment based upon the principles of a Mediterranean diet . All participants are from the Spanish city of Murcia, located on the Southeast coast of the Mediterranean Sea.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Total weight loss
Body weight will be measured in barefoot wearing light clothes, with a digital scale to the nearest 0.1 kg, at the same time each day.
Time frame
weekly, during the 28 weeks of treatment2
Long term weight loss maintenance
Body weight will be measured in barefoot wearing light clothes, with a digital scale to the nearest 0.1 kg.
Time frame
once at least one year after ending the treatmentSecondary outcomes
1
Food timing
Timing of breakfast, lunch and dinner
Time frame
at baseline2
Sleep timing
Habitual sleep timing is estimated using a self-reported questionnaire.
Time frame
at baseline3
Siesta timing questionnaire
Habitual siesta timing is estimated using a self-reported questionnaire.
Time frame
at baseline4
Individual chronotype questionnaire
With the Morning and Eveningness Questionnaire (MEQ)
Time frame
at baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov